Chemoinformaics analysis of DIHYDROSANGUINARINE
| Molecular Weight | 333.343 | nRot | 0 |
| Heavy Atom Molecular Weight | 318.223 | nRig | 29 |
| Exact Molecular Weight | 333.1 | nRing | 6 |
| Solubility: LogS | -7.811 | nHRing | 3 |
| Solubility: LogP | 5.281 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 3 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 47.7099 |
| nHD | 0 | BPOL | 23.7021 |
| QED | 0.624 |
| Synth | 2.766 |
| Natural Product Likeliness | 1.081 |
| NR-PPAR-gamma | 0.047 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.023 |
| Pgp-sub | 0.007 |
| HIA | 0.001 |
| CACO-2 | -5.062 |
| MDCK | 0.0000302 |
| BBB | 0.225 |
| PPB | 0.960863 |
| VDSS | 0.712 |
| FU | 0.0102106 |
| CYP1A2-inh | 0.993 |
| CYP1A2-sub | 0.171 |
| CYP2c19-inh | 0.984 |
| CYP2c19-sub | 0.132 |
| CYP2c9-inh | 0.698 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.988 |
| CYP2d6-sub | 0.928 |
| CYP3a4-inh | 0.915 |
| CYP3a4-sub | 0.135 |
| CL | 16.77 |
| T12 | 0.106 |
| hERG | 0.216 |
| Ames | 0.855 |
| ROA | 0.103 |
| SkinSen | 0.869 |
| Carcinogencity | 0.956 |
| EI | 0.068 |
| Respiratory | 0.906 |
| NR-Aromatase | 0.379 |
| Antiviral | Yes |
| Prediction | 0.800997 |